The fully remote Curator24 may be staffed by 11 full-timers across seven states and Mexico, but the firm’s 2023 track record suggests the lack of day-to-day proximity isn’t a barrier to client engagement. Curator24 grew its account base by eight during the year, adding assignments from Johnson & Johnson Innovative Medicine, Baxter, RegimenPro, Arrowhead Pharmaceuticals, Dilon Technologies (for corporate marketing), Nanos Health (also for corporate marketing), UroGen Pharma (on low-grade upper tract urothelial cancer treatment Jelmyto) and Neurocrine Biosciences (on tardive dyskinesia/Huntington’s disease drug Ingrezza). They joined Astellas, Servier, Homology Medicines and Inari Medical on the agency’s roster.
. . .
